Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prulifloxacin versus levofloxacin for acute exacerbations of chronic bronchitis
2006-004167-56Phase 3Completed
- Sponsor
- Angelini Pharma
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of prulifloxacin and levofloxacin in chronic bronchitis (CB) and bronchitis (2 arms), sponsored by Angelini Pharma. Primary endpoint: Clinical efficacy at test of cure. Started Jul 2007; status: completed.
02
Drugs
prulifloxacinlevofloxacin
03
Conditions
chronic bronchitis (CB)bronchitis
Beyond the preview
Go deeper on 2006-004167-56.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004167-56.